SDHA
- 1 lab in 1 country
- Funder: National Cancer Institute
- Humans1
Associations
2Malignant tumor behavior
upin humans1+47%
1 study
Malignant tumor behavior
upin humans1+47%
SDHA is associated with malignant tumor behavior in humans (47%).
Humansin identified tumors in SDHA carriers
Tumor risks and surveillance outcomes in SDHA variant carriers
Endocrine oncology (Bristol, England)11 Sep 2026
Tumor incidence
upin humans1+15%
1 study
Tumor incidence
upin humans1+15%
SDHA is associated with tumor incidence in humans (15%).
Humansgermline pathogenic or likely pathogenic variantsn = 106
Tumor risks and surveillance outcomes in SDHA variant carriers
Endocrine oncology (Bristol, England)11 Sep 2026
Latest
1 in 12 monthsEndocrine Oncology
Tumor risks and surveillance outcomes in SDHA variant carriers
Cohort study of 106 peoplePopulations